Sickle Cell Disease and Hematopoietic Cell Transplantation

This clinical resource explores HCT as a therapy for patients with sickle cell disease (SCD), by examining the following topics:

• Risk/benefit analysis for treatment decision-making
• Clinical trials, including Medicare coverage for HCT
• Research addressing quality of life issues
• HCT outcomes
• Trends in access to transplant for patients with SCD